161 related articles for article (PubMed ID: 11580146)
1. Microsatellite instability and alternative genetic pathway in intrahepatic cholangiocarcinoma.
Momoi H; Itoh T; Nozaki Y; Arima Y; Okabe H; Satoh S; Toda Y; Sakai E; Nakagawara K; Flemming P; Yamamoto M; Shimahara Y; Yamaoka Y; Fukumoto M
J Hepatol; 2001 Aug; 35(2):235-44. PubMed ID: 11580146
[TBL] [Abstract][Full Text] [Related]
2. Protein expression and genetic alterations of p53 and ras in intrahepatic cholangiocarcinoma.
Furubo S; Harada K; Shimonishi T; Katayanagi K; Tsui W; Nakanuma Y
Histopathology; 1999 Sep; 35(3):230-40. PubMed ID: 10469215
[TBL] [Abstract][Full Text] [Related]
3. Microsatellite alterations in liver fluke related cholangiocarcinoma are associated with poor prognosis.
Limpaiboon T; Krissadarak K; Sripa B; Jearanaikoon P; Bhuhisawasdi V; Chau-in S; Romphruk A; Pairojkul C
Cancer Lett; 2002 Jul; 181(2):215-22. PubMed ID: 12175538
[TBL] [Abstract][Full Text] [Related]
4. Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma.
Kang YK; Kim WH; Lee HW; Lee HK; Kim YI
Lab Invest; 1999 Apr; 79(4):477-83. PubMed ID: 10212000
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of MDM2 protein in intrahepatic cholangiocarcinoma: relationship with p53 overexpression, Ki-67 labeling, and clinicopathological features.
Horie S; Endo K; Kawasaki H; Terada T
Virchows Arch; 2000 Jul; 437(1):25-30. PubMed ID: 10963376
[TBL] [Abstract][Full Text] [Related]
6. Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma.
Isa T; Tomita S; Nakachi A; Miyazato H; Shimoji H; Kusano T; Muto Y; Furukawa M
Hepatogastroenterology; 2002; 49(45):604-8. PubMed ID: 12063950
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability in thorotrast-induced human intrahepatic cholangiocarcinoma.
Liu D; Momoi H; Li L; Ishikawa Y; Fukumoto M
Int J Cancer; 2002 Dec; 102(4):366-71. PubMed ID: 12402306
[TBL] [Abstract][Full Text] [Related]
8. TP53 mutations and mdm2 protein overexpression in cholangiocarcinomas.
Della Torre G; Pasquini G; Pilotti S; Alasio L; Civelli E; Cozzi G; Milella M; Salvetti M; Pierotti MA; Severini A
Diagn Mol Pathol; 2000 Mar; 9(1):41-6. PubMed ID: 10718212
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of mismatch repair genes: a screening tool for predicting mutator phenotype in liver fluke infection-associated intrahepatic cholangiocarcinoma.
Liengswangwong U; Karalak A; Morishita Y; Noguchi M; Khuhaprema T; Srivatanakul P; Miwa M
World J Gastroenterol; 2006 Jun; 12(23):3740-5. PubMed ID: 16773692
[TBL] [Abstract][Full Text] [Related]
10. Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma.
Tannapfel A; Sommerer F; Benicke M; Weinans L; Katalinic A; Geissler F; Uhlmann D; Hauss J; Wittekind C
J Pathol; 2002 Aug; 197(5):624-31. PubMed ID: 12210082
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of microsatellite alterations at 1p36 in cholangiocarcinoma.
Limpaiboon T; Tapdara S; Jearanaikoon P; Sripa B; Bhudhisawasdi V
World J Gastroenterol; 2006 Jul; 12(27):4377-82. PubMed ID: 16865781
[TBL] [Abstract][Full Text] [Related]
12. Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development.
Boberg KM; Schrumpf E; Bergquist A; Broomé U; Pares A; Remotti H; Schjölberg A; Spurkland A; Clausen OP
J Hepatol; 2000 Mar; 32(3):374-80. PubMed ID: 10735605
[TBL] [Abstract][Full Text] [Related]
13. K-ras oncogene and p53 gene mutations in cholangiocarcinoma from Thai patients.
Petmitr S; Pinlaor S; Thousungnoen A; Karalak A; Migasena P
Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):71-5. PubMed ID: 9740272
[TBL] [Abstract][Full Text] [Related]
14. Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand.
Kiba T; Tsuda H; Pairojkul C; Inoue S; Sugimura T; Hirohashi S
Mol Carcinog; 1993; 8(4):312-8. PubMed ID: 8280380
[TBL] [Abstract][Full Text] [Related]
15. Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract.
Abraham SC; Lee JH; Hruban RH; Argani P; Furth EE; Wu TT
Hum Pathol; 2003 Sep; 34(9):902-10. PubMed ID: 14562286
[TBL] [Abstract][Full Text] [Related]
16. MDM2 Amplification in Intrahepatic Cholangiocarcinomas: Its Relationship With Large-Duct Type Morphology and Uncommon KRAS Mutations.
Kim SJ; Akita M; Sung YN; Fujikura K; Lee JH; Hwang S; Yu E; Otani K; Hong SM; Zen Y
Am J Surg Pathol; 2018 Apr; 42(4):512-521. PubMed ID: 29309301
[TBL] [Abstract][Full Text] [Related]
17. Correlation of p53 gene mutation and expression of P53 protein in cholangiocarcinoma.
Liu XF; Zhang H; Zhu SG; Zhou XT; Su HL; Xu Z; Li SJ
World J Gastroenterol; 2006 Aug; 12(29):4706-9. PubMed ID: 16937443
[TBL] [Abstract][Full Text] [Related]
18. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.
Dong LQ; Shi Y; Ma LJ; Yang LX; Wang XY; Zhang S; Wang ZC; Duan M; Zhang Z; Liu LZ; Zheng BH; Ding ZB; Ke AW; Gao DM; Yuan K; Zhou J; Fan J; Xi R; Gao Q
J Hepatol; 2018 Jul; 69(1):89-98. PubMed ID: 29551704
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between genetic alterations and clinicopathological features in intrahepatic cholangiocarcinoma].
Cong W; Finkelstein SD; Wu M
Zhonghua Bing Li Xue Za Zhi; 2001 Jun; 30(3):183-7. PubMed ID: 11866974
[TBL] [Abstract][Full Text] [Related]
20. Allelotypic characteristics of thorotrast-induced intrahepatic cholangiocarcinoma: comparison to liver cancers not associated with thorotrast.
Liu D; Wada I; Tateno H; Ogino D; Suzuki M; Li L; Lu W; Kojiro M; Fukayama M; Okabe H; Fukumoto M
Radiat Res; 2004 Feb; 161(2):235-43. PubMed ID: 14731065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
